Evidence map›Paper›PMID 26634224›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2015

Retinal microvascular network attenuation in Alzheimer's disease.

Michael A Williams, Amy J McGowan, Chris R Cardwell, Carol Y Cheung, David Craig, Peter Passmore, Giuliana Silvestri, Alexander P Maxwell, Gareth J McKay

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Salvage of the retinal ganglion cells in transition phase in Alzheimer's disease with topical coenzyme Q10: is it possible?Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2020
    Trial
  6. Trial
  7. Article
  8. Article
  9. Ocular changes as potential biomarkers for early diagnosis of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Alzheimer's disease pathophysiology in the Retina.Progress in retinal and eye research · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michael A WilliamsCentre for Medical Education, Queen's University Belfast, Belfast, UK.
Amy J McGowanCentre for Public Health, Queen's University Belfast, Belfast, UK.
Chris R CardwellCentre for Public Health, Queen's University Belfast, Belfast, UK.
Carol Y CheungSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore ; Ophthalmology and Visual Sciences Academic Clinical Programme, Duke-NUS Graduate Medical School, National University of Singapore, Singapore, Singapore.
David CraigSouthern Health and Social Care Trust, Craigavon Hospital, Craigavon, UK.
Peter PassmoreCentre for Public Health, Queen's University Belfast, Belfast, UK.
Giuliana SilvestriCentre for Experimental Medicine, Queen's University Belfast, Belfast, UK.
Alexander P MaxwellCentre for Public Health, Queen's University Belfast, Belfast, UK.
Gareth J McKayCentre for Public Health, Queen's University Belfast, Belfast, UK.

Funding

Medical Research Council MR/K003364/1
6 · The paper itself

Abstract

introductionCerebral small-vessel disease has been implicated in the development of Alzheimer's disease (AD). The retinal microvasculature enables the noninvasive visualization and evaluation of the systemic microcirculation. We evaluated retinal microvascular parameters in a case-control study of AD patients and cognitively normal controls.

methodsRetinal images were computationally analyzed and quantitative retinal parameters (caliber, fractal dimension, tortuosity, and bifurcation) measured. Regression models were used to compute odds ratios (OR) and confidence intervals (CI) for AD with adjustment for confounders.

resultsRetinal images were available in 213 AD participants and 294 cognitively normal controls. Persons with lower venular fractal dimension (OR per standard deviation [SD] increase, 0.77 [CI: 0.62-0.97]) and lower arteriolar tortuosity (OR per SD increase, 0.78 [CI: 0.63-0.97]) were more likely to have AD after appropriate adjustment. DISCUSSION: Patients with AD have a sparser retinal microvascular network and retinal microvascular variation may represent similar pathophysiological events within the cerebral microvasculature of patients with AD.

Indexed as

Alzheimer's diseaseMicrocirculationRetinaRetinal vasculatureSmall-vessel disease

Identifiers

PMID26634224
PMCPMC4629099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.